Top compounds associated with response to SPRYD3


Feature Type Standardized
Nominal ANOVA
mRNA VX-11e GDSC1000 pan-cancer AAC 0.077 0.02
mRNA ML320 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.087 0.02
mRNA PD-0325901 CCLE pan-cancer AAC 0.1 0.02
mRNA phloretin CTRPv2 pan-cancer AAC -0.081 0.02
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.078 0.02
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA SGX-523 CTRPv2 pan-cancer AAC 0.085 0.03
Download CSV